Gan & Lee Pharmaceuticals. (SHA:603087)
China flag China · Delayed Price · Currency is CNY
50.33
-0.16 (-0.32%)
May 15, 2025, 3:00 PM CST

SHA:603087 Statistics

Total Valuation

SHA:603087 has a market cap or net worth of CNY 30.15 billion. The enterprise value is 27.80 billion.

Market Cap 30.15B
Enterprise Value 27.80B

Important Dates

The last earnings date was Friday, April 25, 2025.

Earnings Date Apr 25, 2025
Ex-Dividend Date Dec 2, 2024

Share Statistics

SHA:603087 has 598.96 million shares outstanding. The number of shares has increased by 1.40% in one year.

Current Share Class 598.96M
Shares Outstanding 598.96M
Shares Change (YoY) +1.40%
Shares Change (QoQ) +2.58%
Owned by Insiders (%) 31.74%
Owned by Institutions (%) 8.24%
Float 340.68M

Valuation Ratios

The trailing PE ratio is 35.64 and the forward PE ratio is 29.43.

PE Ratio 35.64
Forward PE 29.43
PS Ratio 8.69
PB Ratio 2.66
P/TBV Ratio 2.73
P/FCF Ratio 196.73
P/OCF Ratio 49.04
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 34.51, with an EV/FCF ratio of 181.43.

EV / Earnings 33.47
EV / Sales 8.01
EV / EBITDA 34.51
EV / EBIT 52.31
EV / FCF 181.43

Financial Position

The company has a current ratio of 4.92, with a Debt / Equity ratio of 0.00.

Current Ratio 4.92
Quick Ratio 3.40
Debt / Equity 0.00
Debt / EBITDA 0.01
Debt / FCF 0.07
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is 7.50% and return on invested capital (ROIC) is 3.00%.

Return on Equity (ROE) 7.50%
Return on Assets (ROA) 2.77%
Return on Invested Capital (ROIC) 3.00%
Return on Capital Employed (ROCE) 4.63%
Revenue Per Employee 774,181
Profits Per Employee 185,314
Employee Count 4,482
Asset Turnover 0.29
Inventory Turnover 0.82

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +2.59% in the last 52 weeks. The beta is 1.59, so SHA:603087's price volatility has been higher than the market average.

Beta (5Y) 1.59
52-Week Price Change +2.59%
50-Day Moving Average 46.12
200-Day Moving Average 44.87
Relative Strength Index (RSI) 63.73
Average Volume (20 Days) 12,934,529

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, SHA:603087 had revenue of CNY 3.47 billion and earned 830.58 million in profits. Earnings per share was 1.41.

Revenue 3.47B
Gross Profit 2.63B
Operating Income 531.50M
Pretax Income 877.22M
Net Income 830.58M
EBITDA 797.91M
EBIT 531.50M
Earnings Per Share (EPS) 1.41
Full Income Statement

Balance Sheet

The company has 2.36 billion in cash and 11.46 million in debt, giving a net cash position of 2.35 billion or 3.92 per share.

Cash & Cash Equivalents 2.36B
Total Debt 11.46M
Net Cash 2.35B
Net Cash Per Share 3.92
Equity (Book Value) 11.31B
Book Value Per Share 19.22
Working Capital 3.11B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 614.77 million and capital expenditures -461.53 million, giving a free cash flow of 153.23 million.

Operating Cash Flow 614.77M
Capital Expenditures -461.53M
Free Cash Flow 153.23M
FCF Per Share 0.26
Full Cash Flow Statement

Margins

Gross margin is 75.70%, with operating and profit margins of 15.32% and 23.94%.

Gross Margin 75.70%
Operating Margin 15.32%
Pretax Margin 25.28%
Profit Margin 23.94%
EBITDA Margin 23.00%
EBIT Margin 15.32%
FCF Margin 4.42%

Dividends & Yields

This stock pays an annual dividend of 0.50, which amounts to a dividend yield of 0.99%.

Dividend Per Share 0.50
Dividend Yield 0.99%
Dividend Growth (YoY) n/a
Years of Dividend Growth 1
Payout Ratio 50.63%
Buyback Yield -1.40%
Shareholder Yield -0.40%
Earnings Yield 2.76%
FCF Yield 0.51%
Dividend Details

Stock Splits

The last stock split was on August 20, 2020. It was a forward split with a ratio of 1.4.

Last Split Date Aug 20, 2020
Split Type Forward
Split Ratio 1.4

Scores

Altman Z-Score n/a
Piotroski F-Score n/a